Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart S Winter

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Blood Neoplasia|August 1, 2025
An antibody-drug conjugate targeting VpreB1 for the treatment of B-cell acute lymphoblastic leukemiaPeter M Gordon, Robin L Williams, Jason Ostergaard, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
JAMA Network Open|December 29, 2022
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic LeukemiaWenjian Yang, Seth E Karol, Keito Hoshitsuki, et al.
Blood Advances|July 23, 2021
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphomaXinjie Xu, Christian N Paxton, Robert J Hayashi, et al.
Blood|February 4, 2010
Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Wenxue Ma, et al.
Science Signaling|March 28, 2013
Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesisCatherine Hartzell, Olga Ksionda, Ed Lemmens, et al.
Blood|May 22, 2009
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Pediatric Blood & Cancer|March 11, 2015
Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Blood Neoplasia|August 1, 2025
An antibody-drug conjugate targeting VpreB1 for the treatment of B-cell acute lymphoblastic leukemiaPeter M Gordon, Robin L Williams, Jason Ostergaard, et al.
SLAS Discovery : Advancing Life Sciences R & D|May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALLDominique R Perez, Christian K Nickl, Anna Waller, et al.
JAMA Network Open|December 29, 2022
Association of Inherited Genetic Factors With Drug-Induced Hepatic Damage Among Children With Acute Lymphoblastic LeukemiaWenjian Yang, Seth E Karol, Keito Hoshitsuki, et al.
Blood Advances|July 23, 2021
Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphomaXinjie Xu, Christian N Paxton, Robert J Hayashi, et al.
Blood|February 4, 2010
Inactivation of LEF1 in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Wenxue Ma, et al.
Science Signaling|March 28, 2013
Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesisCatherine Hartzell, Olga Ksionda, Ed Lemmens, et al.
Blood|May 22, 2009
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Takaomi Sanda, Ruta Grebliunaite, et al.
Blood|August 9, 2023
Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group studyBrent L Wood, Meenakshi Devidas, Ryan J Summers, et al.
Pediatric Blood & Cancer|March 11, 2015
Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434Stuart S Winter, Kimberly P Dunsmore, Meenakshi Devidas, et al.
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.
Pageof 8